Next Article in Journal
The Commensal Microbiota Enhances ADP-Triggered Integrin αIIbβ3 Activation and von Willebrand Factor-Mediated Platelet Deposition to Type I Collagen
Next Article in Special Issue
Novel Programmed Cell Death as Therapeutic Targets in Age-Related Macular Degeneration?
Previous Article in Journal
The Interplay between Transcriptional Factors and MicroRNAs as an Important Factor for Th17/Treg Balance in RA Patients
Previous Article in Special Issue
Hypothermically Stored Adipose-Derived Mesenchymal Stromal Cell Alginate Bandages Facilitate Use of Paracrine Molecules for Corneal Wound Healing
Open AccessReview
Peer-Review Record

Oxidative Stress and Microglial Response in Retinitis Pigmentosa

Int. J. Mol. Sci. 2020, 21(19), 7170; https://doi.org/10.3390/ijms21197170
Reviewer 1: Anonymous
Reviewer 2: Enzo Maria Vingolo
Int. J. Mol. Sci. 2020, 21(19), 7170; https://doi.org/10.3390/ijms21197170
Received: 12 September 2020 / Accepted: 27 September 2020 / Published: 28 September 2020
(This article belongs to the Special Issue Molecular Research on Stress Response and Ocular Homeostasis)

Round 1

Reviewer 1 Report

The paper is very important from clinical point of view.

Retinitis pigmentosa belongs among hereditary diseases, however, nongenetic factors, maily oxidative stress, contribute to the disease progression.

However, the use of various antioxidants did not provide expected results in animal models or clinical trials.

The authors summarize in their review the current results with the use of various antioxidants with the aim to improve the disease.

The review highly contributes to the elucidation of the role of oxidative stress in retinitis pigmentosa necessary for

the development of a novel antioxidant strategy and therapy. 

 

Reviewer 2 Report

the paper is an interesting review on the effects of ROS in progression of retinitis pigmentosa, there is a lack inconnexion between clinical aspects in human and alterations that it is possible recognize at molecular level, but the paper seems to open a new windov on retinal treatment in several clinical conditions

Back to TopTop